4.8 Article Proceedings Paper

Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 282, Issue -, Pages 13-24

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2018.02.042

Keywords

-

Funding

  1. National Heart, Lung and Blood Institute (NHLBI) [HL125462, HL128398, HL126874, T32 HL007954, T32 HL774819, T32 HL007915]
  2. NSF [PD 09-6885, CHE-1508318]

Ask authors/readers for more resources

Ferritin subunits of heavy and light polypeptide chains self-assemble into a spherical nanocage that serves as a natural transport vehicle for metals but can include diverse cargoes. Ferritin nanoparticles are characterized by remarkable stability, small and uniform size. Chemical modifications and molecular re-engineering of ferritin yield a versatile platform of nanocarriers capable of delivering a broad range of therapeutic and imaging agents. Targeting moieties conjugated to the ferritin external surface provide multivalent anchoring of biological targets. Here, we highlight some of the current work on ferritin as well as examine potential strategies that could be used to functionalize ferritin via chemical and genetic means to enable its utility in vascular drug delivery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available